INR Normal Range
May 11, 2022
Source: Cainiu Health
Dr. Tian Hongbo
Introduction
The INR (International Normalized Ratio) is derived from the prothrombin time (PT) and is used to assess the body’s coagulation function. A higher INR value indicates that blood takes longer to clot, reflecting weaker coagulation function. Within this range, coagulation function is considered normal. For patients not taking anticoagulant medications, the normal INR range is 0.8–1.3. This range may change when anticoagulant therapy is initiated.
Under normal circumstances, the reference range for INR is 0.8–1.5. The analysis is as follows:
INR (International Normalized Ratio) is derived from prothrombin time (PT) and is used to assess overall coagulation function. A higher INR value indicates a longer time required for blood to clot, reflecting weaker coagulation capacity. Within this reference range, coagulation function is considered normal.
In patients not receiving anticoagulant therapy, the normal INR range is typically 0.8–1.3. However, in those taking anticoagulants, the target INR range shifts accordingly. For patients with venous thrombosis, the therapeutic INR target is generally 2.0–2.5.
An elevated INR often suggests impaired coagulation function and an increased risk of bleeding. Potential underlying causes include disseminated intravascular coagulation (DIC), vitamin K deficiency, hepatic dysfunction, or rheumatic and autoimmune disorders. In such cases, patients should promptly seek medical evaluation to identify and treat the underlying cause.
If the INR falls outside the target range—either too high or too low—patients must adjust their medication dosage or type under the guidance of a physician to minimize risks of bleeding or thrombosis.
